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ABSTRACT
Plant based antimicrobials represent a vast potential of untapped sources of medicines. 
Antimicrobial sensitivity patterns change over time due to resistance developed by 
microorganisms, underpinning the great need for search of novel antimicrobial drugs. 
Phytochemical and antibacterial effects of crude aqueous (hot and cold) and alcohol extracts of 
stem bark of Brachystegia eurycoma was investigated using standard methods. The preliminary 
phytochemical screening revealed the presence of saponins, alkaloids, steroids and tannins as 
major components. Also, of the three different extracts tested against four pathogenic bacteria 
(Sphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and Proteus vulgaris), only the 
cold aqueous extract showed a mild zone of inhibition (3mm) against Escherichia coli, with an 
MIC of 12.5mg/ml and MBC of 25mg/ml. This suggests that cold aqueous extract of B. Eurycoma 
has antibacterial activity, which might account for its inclusion in traditional herbal preparations in 
the treatment of wounds and infections.  
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INTRODUCTION
Plants are the source of some very useful drugs (Parfitt, 1978). It is estimated that plant materials have provided the 
models for about 50% of orthodox drugs (Sofowora, 1993). Several investigations have been conducted on 
medicinal properties of herbs,  trees and shrubs; good examples include the isolation of  cardiac glycosides (digoxin) 
from Digitalis purpurea, quinine from cinchona bark, reserpine from Rauolfia spp (serpentina and vomitoria),
physostigmine or eserine from Physostigma venenosum (the Calabar bean), anticancer taxols from Taxus spp, the 
spindle poisons (vincristine and congeners from  Catharanthus roseus -Vinca or Madagascar Rose periwinkle), 
which are used in the management of leukaemia and Hodgkin’s disease (Reis and Lipp, 1982).  By the early 
nineties, screening work on African medicinal plants has advanced with publications arising from the following 
research areas: antimicrobial (16%), molluscicidal (11%), antimalarial (7%), plant toxicology (7%), antitumour-
related studies (4%) and others (54%) (Sofowora, 1993). Indeed, many studies have revealed the antimicrobial 
potency of a variety of plants and plant products like Allium sativum (Block, 1985); Acapyphaterta (Akinyanji et al., 
1986); Nutmeg -Myristica frangrans, Kola nut- Kola nitida (Njoje, 1997) and Japanese green tea (Thomas, 2001). 
Similarly, Aloe vera has antimicrobial effects that is useful in the treatment of burns and also aids the healing 
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process (Fajimi et al., 2004), while Dogon-yaro (Azadiractha indica) has analgesic and antibacterial properties 
(Obadoni and Ochuko, 2001). 
Available literature have shown that various parts of the tree of Brachystegia eurycoma known as Achi (in Igbo), 
Akalado or Eku (in Yoruba), Akpakpa or Taura ( in Hausa), Apaupan (in Ijaw), Okweri (in Edo), Okung (in Efik)
and Okwen, “Ukpantoton or Odukpa (in Ibibio) are used as food additives and as medicine. Among the Igbos of 
South East, Nigeria, the seed is used as thickening agent for soup and as a flavoring agent (Enwere, 1998). The seed 
is a good source of nutrients and rich in carbohydrate and fiber. It is known to control body temperature, softens 
stool, and protects against colon and rectal cancer (Ndukwu, 2009). Its blood sugar and cholesterol lowering effects 
and the ability to lower the risk of heart diseases has been reported (Okwu, 2004). The stem bark is reported to have 
diuretic effects and anti-inflammatory activities, which makes it useful in some gynaecological conditions such as 
premenstrual syndrome and uterine fibroids (Adikwu and Nwosu, 1998). 
Further investigations have also shown that Brachystegia eurycoma has antifungal activities and in combination 
with snail mucin and honey in native treatment of wound and can prevent scar formation, as well as promote the 
regeneration of hair follicles (Adikwu and Enebeke, 2007). The red liquid gum of the stem bark is used as binding 
substance in pharmaceutical industry (Ikegwu et al., 2010). Extracts of B. eurycoma inhibited the growth and 
celluloytic activity of Bacillus subtilis (Beguin, 1990). Adekunle (2000) reported that water extracts of B. eurycoma
has antifungal activities against various species of fungi; but the ground powder quickly became contaminated and 
yielded Aspergillus species. Aflatoxins produced by Aspergillus flavus and Aspergillus parasiticus are teratogenic, 
mutagenic and carcinogenic (hepatic carcinoma), and have been associated with growth retardation, underweight 
and modification of immune function in West African children (Gong et al., 2002). 
Johnny et al. (2014) tested the potency of ethanolic extracts of B. eurycoma seed against some pathogenic bacteria 
such as Bacillus subtillis, Pseudomonas aeruginosa, Shigella spp, Escherichia coli and found that all the organisms 
tested were sensitive to the undiluted crude extract and compared favorably with ciprofloxacin. Okenwa and 
Echeme (2013) showed that naphthalene pentenoic acid from ethanol extract of the stem bark of B. eurycoma has 
marked antibacterial activity against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and 
Streptococcus fecalis. In addition, Brachystegia eurycoma contain B vitamins (thiamin, riboflavin, and niacin), 
ascorbic acid as well as minerals such as calcium, potassium, sodium,  phosphorus, magnesium, zinc, iron, and 
copper- a confirmation of its nutritional values (Okwu, 2004; Bolanle et al., 2014). 
In addition, the phytochemical analysis of seeds and stem bark of B. eurucoma revealed tannins, terpenes, 
flavonoids, saponins,  phenols, cardiac glycosides and antioxidants (Igwe and Okwu, 2013a,b; Okwu and Okoro , 
2006; Johnny et al., 2014). Anthraquinones and phlobatannins were not detected in the seed extracts (Johnny et al., 
2014). The presence of the antioxidant phytochemicals may underlie the basis for the use of the plant in the 
treatment/management of tissue inflammation, arthritis, wounds, cancer, artherosclerosis and other cardiovascular 
disorders (Igwe and Okwu, 2013). 
Regardless of the fact that fungi were the original sources of very potent antibacterial drugs, plant based 
antimicrobials represent a vast potential of untapped sources of medicines and antimicrobial sensitivity patterns 
change over time, as micro organisms constantly develop resistance to existing antimicrobial drugs. This worrisome 
trend makes the continuous search for new and more efficacious antimicrobial agents imperative (Hesing, 2001). 
The last decade witnessed an increase in the investigation of plants as a source of drugs for treatment of disease for 
plant, animals and man (Aiyelagabe, 2000). Overcoming antimicrobial resistance is therefore a major challenge in 
this millennium (WHO, 2002). This study therefore, was designed to analyze the phytochemical contents of stem 
bark of  Brachystegia eurycoma and determine the antibacterial activities of  its various crude extracts (aqueous –
hot/cold and alcohol) on selected bacterial pathogens (Staphylococcus aureus, Escherichia coli, Pseudomonas 
eurugenosa, Proteus vulgaris)
   
MATERIALS AND METHODS
Collection and preparation of Brachystegia eurycoma: Fresh stem bark of Braschystegia eurycoma was obtained 
from Umuaku Isuochi, Umunneochi Local Government Area, Abia State, South East, Nigeria, and identified by the 
Taxonomist at the Herbarium in the Department of Botatny, Ambrose Alli University, Ekpoma. Voucher specimen 
number AAUBH00115. The peeled bark of B. Eurycoma was sun-dried and weighed daily for three (3) weeks, until 
a constant weight was obtained. Inside a fume cupboard, the chopped pieces of the dried bark were then pulverized 
to powder using clean sterile ceramic mortar and pestle, which had been sterilized by flaming. The B. eurycoma
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powder was sieved (0.23µm) to remove larger particles and then stored in airtight glass containers protected from 
direct sunlight until required for use.  
Experimental procedure: The extraction, phytochemical analysis and antibacterial sensitivity were carried out at 
CDR Laboratory, an accredited/ registered medical laboratory (MLSCN RF 918) at Ekpoma, South-South, Nigeria 
using standard procedures; the antibacterial sensitivity tests used was agar diffusion according to the methods of 
Schwalbe et al. (2007). Sterile distilled water was used as negative control while ciprofloxacin and tetracycline 
served as positive controls.
Crude extraction: One gram (1g) each of B. eurycoma powder was placed into three different sterile universal 
bottles (labelled A, B, C), each with 10ml of cold distilled water, hot water (80oC), and 70% ethanol respectively 
and shaken every 30minutes for three hours in each case. The samples were allowed to stand for twenty four (24) 
hours, after which they were filtered using Whatman’s No 1 filter paper. The filtrates were appropriately labeled and 
allowed to evaporate to dryness in the Gallenkemp oven drier at 40oC. The labeled extracts were stored in the 
refrigerator at 40C until used for this experiment.
Phytochemical analysis: Qualitative phytochemical test involved the simple chemical test to detect the secondary 
metabolites using standard method of Trease and Evans (2009). For each of the cold water, hot water, and ethanol 
extracts powder of B. Eurycoma qualitative phytochemical screening was determined for the presence of: tannins, 
saponins, cardiac glycosides, steroids, alkaloids and flavonoids, One gram (1g) of the powder was subjected to 
qualitative phytochemical tests for Alkaloid (Mayer reagent); Tannins (FeCl3); Saponins (chloroform and H2SO4); 
Cardiac glycosides (glacial acetic acid + FeCl3 + H2SO4.); Steroid (chloroform + acetic anhydride + Conc. H2SO4); and 
Flavonoid (5ml of Ammonia solution + H2O). Total phenolic content was estimated spectrophotometrically using 
Folin Ciocalteu reagent, as described by Spanos and Wrolstad (1990), with slight modification using Gallic acid as a 
standard.
Antibacterial Sensitivity Test: For the antibacterial sensitivity tests, agar diffusion and broth dilution methods were 
used according to Schwalbe et al., 2007. 5.6g of nutrient agar was weighed and diluted with 200ml of sterile 
distilled water, mixed and sterilized at 21oC for 15minutes, allowed to cool and then poured into different sterile 
Petri dishes to solidify. The Nutrient agar plates were dried and each was inoculated with the bacterial isolates 
(Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and Proteus vulgaris), isolated from urine 
samples of patients with urinary tract infections, using standard procedure. Different concentrations of the various 
extracts (cold water, hot water, alcohol) were absorbed on standard  filter paper discs and applied on the inoculated 
isolates along with control discs (sterile distilled water, ciprofloxacin and tetracycline). All the cultures were 
incubated for 24hours at 37o C. The Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal 
Concentration (MBC) respectively of the cold water extract of B. eurycoma were determined according to the 
method of Schwalbe et al., 2007.   
RESULTS
The qualitative screening results showed the presence of moderate quantities (++) of tannins, saponins, phenols and 
flavonoids, and low concentrations (+) of alkaloid, cardiac glycosides and steroids (Table 1).
Table 1: Phytochemistry of stem bark of B. eurycoma
Tannins Saponin Flavonoid Cardiac 
Glycoside
Alkaloid Steroids Phenol
++ ++ ++ + + + ++
    
Of all the preparations of B. eurycoma, only the cold aqueous extract showed significant zone of inhibition for E. 
coli. Hot aqueous and alcohol extracts showed no zone of inhibition. All the bacterial organisms tested 
(Staphylococcus aureus, Escherichia coli, Pseudomonas eurugenosa, and Proteus vulgaris) were inhibited by 
ciprofloxacin, while Staphylococcus aureus and Escherichia coli were inhibited by tetracycline. Cold aqueous 
extract and tetracycline showed the same zone of inhibition to Escherichia coli. The negative control containing 
sterile distilled water showed no zone of inhibition (Tables 2 and 3) 
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Specifically, table 2 below shows the sensitivity of the organisms and diameters of zones of inhibition in millimeters 
(mm) by the various extracts of Brachystegia eurycoma, and the controls- sterile distilled water (placebo) and the 
antibiotics - ciprofloxacin and tetracycline. The Minimum Inhibitory Concentration (MIC) and Minimum 
Bactericidal Concentration (MBC) of cold aqueous extract of B. eurycoma on Escherichia coli as shown in table 3, 
was 12.5mg/ml and was 25mg/ml respectively.
Table 2: Sensitivity and diameters of zones of inhibition 




mg/ml)Hot Water Cold water Alcohol
Staphylococus aureus 0 0 0 16 12
Escherichia coli 0 3 0 12 2
Pseudomonas. 
aeruginosa
0 0 0 18 12
Proteus vulgaris 0 0 0 5 3
Table 3: Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)
Extract conc. (mg/ml) 100 50 25 12.5 6.25 3.125
MIC Inhibition + + + + -
MBC Inhibition + + + - - -
Key: + Growth; - No growth
DISCUSSION:
Phytochemical screening helps to assess the chemical constituents of plant extracts. It may also be used to search for 
bioactive agents that could be used in the synthesis and formulation of drugs (Yakubu et al., 2005). Phytochemical 
screening of the stem bark of Braschystegia eurycoma revealed the presence of tannins, saponins, flavonoids and 
phenols, as the major phytochemical components (Table 1). Alkaloids, steroids and cardiac glycosides content were
moderate. These findings are similar to that of Igwe and Okwu (2013).
On the other hand, studies have shown that flavonoids in many plant parts have multiple biological activities, 
including antioxidant (Steffan, et al., 2005, Cushnie and Lamb, 2005), vasodilatory, anticarcinogenic, anti-
inflammatory, antibacterial (Ao et al., 2008), anti-allergic, antiviral, estrogenic and immune system stimulating 
effects (Cowan, 1999). Thus, the detection of moderate quantity of flavonoids in the stem bark of B. eurycoma
confers both nutritional and medicinal value on the plant. Similarly, the presence of saponin in the stem bark of B. 
eruycoma may also account for the results of this study as saponin possess antibacterial (Rebeiro et al., 1995) and 
antifungal properties (Escalate et al., 2002, Joyce et al., 2007).
Other secondary metabolites in B. eurycoma included alkaloids, tannins and phenols. A review of the literature 
shows that alkaloids are plant bases that exhibit certain physiological properties when used in herbal medicine. Most 
of them have anti-malarial, antifungal and antimicrobial activities (Scalbert, 1991). Tannins in plants are known to 
improve healing of ulcers and burns, and also known for their antioxidant and antimicrobial properties. It possesses
astringent properties and is thought to act as inhibitors of oxidative phosphorylation and electron transport (by 
depletion of iron); thus depriving bacteria of iron (Scalbert, 1991). In addition, B. eurycoma contains phenol and this 
phytochemical is known to possess anti-inflammatory and antimicrobial properties (Joyce et al., 2007).
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Indeed, there is an ever increasing need for newer antibacterial agents on account of development of bacterial 
resistance to the existing ones. B. eurycoma is a plant used in trado-medical practice in the treatment of sexually 
transmitted diseases, purportedly for its antibacterial effects. The observed inhibition of Esch. coli in this study has 
justified its use in the trado-medical circle, as the cold aqueous extracts showed a 3mm zone of inhibition against 
Escherichia coli in a disc agar plate (Table 2); slightly more than the 2mm zone shown by tetracycline, but far less 
than the 12mm zone of inhibition shown by ciprofloxacin - both used as positive controls. It can be said that with the 
MIC of 12.5mg/ml and MBC of 25mg/ml and 3mm zone of inhibition, the cold water extract of B. eurycoma could 
be more effective than tetracycline, but less so for ciprofloxacin; bearing in mind the pharmacokinetic influences 
and its potential toxicities, which was not part of the design of this particular study. This finding is similar to that of 
Okenwa and Echeme (2013), who showed that 4-(4-phenyl-,4-dihydronaphthalen-1yl) Pentenoic Acid from the 
Stem Bark of Brachystegia eurycoma has antibacterial activity against Staphylococcus aureus, Pseudomonas 
aeruginosa and Streptococcus fecalis; further justifying the use of the extracts of the plant in traditional medical 
practice for the treatment of gonorrhea and other infections, including healing of wounds. However, the hot aqueous 
and alcohol extracts of B. eurycoma did not show any zone of inhibition (Table 2). The phytochemicals could have 
been retained in the cold aqueous extract and could be heat sensitive and hence destroyed in the hot water extract. It 
could also be that some of the active principle of the plant did not dissolve in the solvents used in the present study 
(Ellof, 1998).
Concerning the inhibition against Escherichia coli, the antibacterial effects of Brachystegia eurycoma could be 
attributed to the presence of chemical substances such as resins, flavonoids, taninins and phenols which are known 
to inhibit the growth of bacteria (Obadoni and Ochuko, 2001) and act by inhibiting DNA synthesis, cytoplasmic 
membrane function as well as inhibition of energy metabolism in bacteria (Cowan, 1999, Cushnie, 2005).  
Furthermore, the organisms that did not show zones of inhibition (Pseudomonas aeruginosa, Proteus vulgaris and 
Staphylococcus aureus) and were adjudged resistant are known to be resistant to multiple antibiotics by various 
mechanisms; even though they were sensitive to the standard antibiotics in this work. One or more of these 
mechanisms may be in operation in the present study for the hot aqueous and alcohol extracts of Brachystegia 
eurycoma. E. coli, the organism sensitive to the cold aqueous extract may not have acquired the resistant factor(s). 
In conclusion, the cold aqueous extract of the bark of Brachystegia eurycoma had antibacterial activity against 
Escherichia coli and may be used against infections caused by this organism if further toxicological and 
pharmacokinetic studies confirm it to be safe. The findings have also justified its use in trado-medical practice in the 
treatment of infections and for the healing of wounds. It is our recommendation therefore, that further studies using 
more bacterial organisms be carried out to ascertain the antibacterial spectrum of cold aqueous extract of 
Brachystegia eurycoma.
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